# Nautilus Biotechnology, Inc.: Form SCHEDULE 13D/A, filed Jun 24, 2025

- Company: [Nautilus Biotechnology, Inc.](/companies/naut.md) (CIK 1808805)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-24
- Accepted by EDGAR: Jun 24, 2025, 16:42 ET
- Period: not reported
- Accession: 0001104659-25-062136
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1808805/000110465925062136/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808805/000110465925062136/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808805/000110465925062136/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-062136. Last ingested by Listed: Oct 27, 2026, 07:43 ET. No prices; not investment advice.